2BB score and signals
LENZ Therapeutics, Inc.’s current 2BB score is 33 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 11 | Very Low |
| Momentum | 18 | Strongly Weakening |
| Financial strength | 43 | Normal |
| Quality | 100 | Very Strong |
| Risk | 47 | Moderate |
Company facts
| Headquarters | Solana Beach, California, United States |
| Founded | 2013 |
| Employees | 152 |
| 52-week range | $4.61 – $50.19 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-03 | — | -0.9158 | — | $4.87M |
| 2026-08-11 | -1.02 | -1.0962 | $5.49M | $2.42M |
| 2026-05-11 | -1.32 | -1.0905 | $1.90M | $1.79M |
| 2026-03-24 | -1.16 | -0.9906 | $1.59M | $1.92M |
Related companies
2BBBullish & Bearish